Merck & Co., Inc. (MRK)
122.41
+6.53
(+5.64%)
USD |
NYSE |
May 22, 16:00
122.56
+0.15
(+0.12%)
Pre-Market: 20:00
Merck Free Cash Flow : 14.12B for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 17.80B |
| Eli Lilly & Co. | 10.37B |
| Pfizer Inc. | 9.484B |
| Bristol Myers Squibb Co. | 11.91B |
| Organon & Co. | 708.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.918B |
| Cash from Investing (Quarterly) | -10.21B |
| Cash from Financing (Quarterly) | -2.981B |
| Free Cash Flow Per Share (Quarterly) | 1.184 |
| Free Cash Flow to Equity (Quarterly) | 4.344B |
| Free Cash Flow to Firm (Quarterly) | 3.502B |
| Free Cash Flow Yield | 4.63% |